$6.82
0.59% yesterday
Nasdaq, Jul 03, 10:00 pm CET
ISIN
US6024961012
Symbol
MDXG
Sector
Industry

MiMedx Group, Inc. Share price

$6.82
-0.28 3.94% 1M
-0.96 12.28% 6M
-1.95 22.23% YTD
+0.22 3.33% 1Y
-5.58 45.00% 3Y
+2.47 56.78% 5Y
-0.62 8.33% 10Y
Nasdaq, Closing price Wed, Jul 03 2024
+0.04 0.59%
ISIN
US6024961012
Symbol
MDXG
Sector
Industry

Key metrics

Market capitalization $1.01b
Enterprise Value $977.62m
PER (TTM) P/E ratio 14.69
EV/FCF (TTM) EV/FCF 29.45
EV/Sales (TTM) EV/Sales 2.92
P/S ratio (TTM) P/S ratio 3.01
P/B ratio (TTM) P/B ratio 6.46
Sales growth (TTM) Sales growth 19.20%
Turnover (TTM) Turnover $334.51m
EBIT (operating result TTM) EBIT $45.81m
Free cash flow (TTM) Free cash flow $33.20m
Cash position $48.49m
EPS (TTM) EPS $0.46
P/E ratio expected 22.31
P/S ratio expected 2.79
EV/Sales expected 2.71
Short interest 4.74%
Show more

Is MiMedx Group, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.

MiMedx Group, Inc. Share analysis

Unlock Scores for Free

Analyst opinions

6 Analysts have issued a MiMedx Group, Inc. forecast:

6x Buy
100%

Analyst opinions

6 Analysts have issued a MiMedx Group, Inc. forecast:

Buy
100%

Financial data from MiMedx Group, Inc.

Mar '24
+/-
%
Net profit 9.26 9.26
286% 286%
11%
Depreciation and amortization 0.75 0.75
40% 40%
1%
Share compensation 4.34 4.34
0% 0%
5%
Operating cash flow 4.88 4.88
220% 220%
6%
Investments 1.14 1.14
68% 68%
1%
Dividend paid - -
-
-
Free cash flow 3.73 3.73
180% 180%
4%

Figures in millions USD.

Don't miss a thing! We will send you all news about the MiMedx Group, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

MiMedx Group, Inc. Share News

Positive
InvestorPlace
2 days ago
Every investment category must answer the big question, why? For undervalued biotech stocks, it comes down to advantaging a supremely relevant sector without paying full price.
Neutral
GlobeNewsWire
7 days ago
MARIETTA, Ga., June 26, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the appointment of Kim Moller to Chief Commercial Officer. Ms. Moller has been serving as the Company's Senior Vice President, Sales since August 2020.
Neutral
GlobeNewsWire
about 2 months ago
MARIETTA, Ga., May 15, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
More MiMedx Group, Inc. News

Company profile

MiMedx Group, Inc. is an advanced wound care and an emerging therapeutic biologics company. It engages in developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. The company processes the human placental tissue utilizing its proprietary PURION process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. MiMedx Group was founded on July 30, 1985 and is headquartered in Marietta, GA.

Head office United States
CEO Joe Capper
Employees 895
Founded 1985
Website www.mimedx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today